Immediate Impact

50 standout
Sub-graph 1 of 24

Citing Papers

Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review
2025 Standout
Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
2024 Standout
3 intermediate papers

Works of Antoni Sicras being referenced

The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease
2022
PNL3 RETROSPECTIVE COMPARATIVE ANALYSIS OF ANTIDEMENTIA MEDICATION PERSISTENCE PATTERNS AT 3 YEARS IN SPANISH ALZHEIMER DISEASE PATIENTS TREATED WITH DONEPEZIL, RIVASTIGMINE, GALANTAMINE AND MEMANTINE
2005

Author Peers

Author Last Decade Papers Cites
Antoni Sicras 86 104 82 127 99 27 501
Laure de Decker 52 56 72 54 56 46 500
L. Parker Gregg 68 41 56 83 42 32 504
Janaka Lovell 28 67 34 139 109 13 458
Natalia Świątoniowska-Lonc 85 81 69 35 138 46 533
Anna Chudiak 28 47 104 64 122 27 553
Xianxiu Wen 41 49 153 52 88 36 562
Rebecca Shackelton 116 80 19 65 166 18 486
Marion Biermans 137 50 32 50 107 30 514
Chulaporn Limwattananon 47 50 37 50 44 37 522
Fabio Samani 44 41 24 56 71 14 419

All Works

Loading papers...

Rankless by CCL
2026